CD8A and serum lipopolysaccharide activity: However, in animal models of endotoxemia, OA has been shown to partially hinder the development of CD8+ T cells into the Teff subpopulation, decrease the expression of Teff effector molecules, diminish inflammation, and alleviate the symptoms of endotoxemia.